MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2019 International Congress

    Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson’s Disease

    A. Martini, L. Weis, E. Fiorenzato, R. Schifano, V. Cianci, A. Antonini, R. Biundo (Newcastle-­under­-Lyme, United Kingdom)

    Objective: To investigate whether Parkinson’s disease (PD) cognitive states and phenotypes are associated with changes in prevalence and severity of Impulse control disorder (ICD). Background:…
  • 2019 International Congress

    Cortical FDG-PET patterns predict long-term motor progression and disability milestones in Parkinson’s disease

    A. Pilotto, A. Imarisio, E. Premi, SP. Caminiti, L. Presotto, A. Sala, R. Turrone, R. Grasso, A. Alberici, B. Paghera, MC. Rizzetti, B. Borroni, D. Perani, A. Padovani (Brescia, Italy)

    Objective: To evaluate the accuracy of single-subject FDG-PET in predicting motor and cognitive long-term progression in Parkinson's disease Background: The progression of Parkinson's disease is…
  • 2019 International Congress

    Introduction of an Assessment Toolkit Increases the Rate of DLB Diagnosis

    A. Surendranathan, J. Kane, A. Bentley, S. Barker, J. Taylor, A. Thomas, I. Mckeith, D. Burn, J. O'Brien (Cambridge, United Kingdom)

    Objective: To assess whether diagnostic rates of both Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) could be increased by the introduction of…
  • 2019 International Congress

    A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson’s disease dementia

    P. Svenningsson, P. Odin, N. Dizdar, F. Bergquist, A. Johansson, D. Nyholm, K. Wictorin, J. Tedroff (Uppsala, Sweden)

    Objective: The primary objective was to investigate the safety and tolerability of IRL752 in PD patients with dementia in a randomized controlled trial. Secondary outcome…
  • 2019 International Congress

    Characteristic Parkinsonism Questionnaire for the Discrimination of Parkinson’s Disease Dementia from Vascular Dementia

    PY. Chiu (Changhua, Taiwan)

    Objective: We have designed a characteristic 8-item parkinsonism questionnaire for the screening of motor dysfunction due to Lewy body dementia (LBD). We aim to test…
  • 2019 International Congress

    Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease

    T. Tropea, L. Baratta, K. Maddy, M. Guo, J. Rick, V. van Deerlin, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

    Objective: To investigate whether susceptibility loci for Alzheimer's disease (AD) are associated with rates of longitudinal cognitive decline in Parkinson’s disease (PD). Background: Parkinson’s disease…
  • 2019 International Congress

    Clinico-pathological Findings In Autopsy Cases With Non-Specific Glial Tauopathy

    E. Zamrini, CH. Adler, GE. Serrano, N. Zhang, DR. Shprecher, SH. Mehta, MN. Sabbagh, E. Driver-Dunckley, HA. Shill, LI. Sue, TG. Beach (Sun City, AZ, USA)

    Objective: Determine Clinico-pathological correlates of aging-related tau astrogliopathy (ARTAG). Background: Aging-related tau astrogliopathy (ARTAG) appears to be a morphological spectrum of astroglial pathology mostly seen in…
  • 2019 International Congress

    An Informant-based Simple Questionnaire for Executive Function Assessment in Dementia with Lewy Bodies and Alzheimer’s Disease

    YS. Liang, GU. Hung, CY. Wei, PY. Chiu (Changhua, Taiwan)

    Objective: The aim of this study was to investigate and compare executive dysfunction by using a newly designed informant-based simple questionnaire among patients with DLB…
  • 2019 International Congress

    Spontaneous Pisa Syndrome in a Patient with Early-onset Alzheimer’s Disease

    KA. Woo, D. Yoo, JY. Lee (Seoul, Republic of Korea)

    Objective: We report a case of early-onset AD where spontaneous Pisa syndrome predominated. Background: Pisa syndrome, an involuntary, reversible lateral deviation of the trunk, was…
  • 2019 International Congress

    In vivo and In vitro study of 17β estradiol against amyloid beta neurotoxicity in synaptosomes of aging female rats : A therapeutic potential drug for Alzheimer’s disease

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The aim of the present study was to determine the effects of neuropeptide, neurokinin B (NKB) and amyloid beta fragment Aβ (25-35) on 17β…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley